Methods and Applications of Statistics in Clinical Trials, Volume 2
eBook - ePub

Methods and Applications of Statistics in Clinical Trials, Volume 2

Planning, Analysis, and Inferential Methods

  1. English
  2. ePUB (mobile friendly)
  3. Available on iOS & Android
eBook - ePub

Methods and Applications of Statistics in Clinical Trials, Volume 2

Planning, Analysis, and Inferential Methods

About this book

Methods and Applications of Statistics in Clinical Trials, Volume 2: Planning, Analysis, and Inferential Methods includes updates of established literature from the Wiley Encyclopedia of Clinical Trials as well as original material based on the latest developments in clinical trials. Prepared by a leading expert, the second volume includes numerous contributions from current prominent experts in the field of medical research. In addition, the volume features:

• Multiple new articles exploring emerging topics, such as evaluation methods with threshold, empirical likelihood methods, nonparametric ROC analysis, over- and under-dispersed models, and multi-armed bandit problems

• Up-to-date research on the Cox proportional hazard model, frailty models, trial reports, intrarater reliability, conditional power, and the kappa index

• Key qualitative issues including cost-effectiveness analysis, publication bias, and regulatory issues, which are crucial to the planning and data management of clinical trials

Frequently asked questions

Yes, you can cancel anytime from the Subscription tab in your account settings on the Perlego website. Your subscription will stay active until the end of your current billing period. Learn how to cancel your subscription.
No, books cannot be downloaded as external files, such as PDFs, for use outside of Perlego. However, you can download books within the Perlego app for offline reading on mobile or tablet. Learn more here.
Perlego offers two plans: Essential and Complete
  • Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
  • Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
Both plans are available with monthly, semester, or annual billing cycles.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, we’ve got you covered! Learn more here.
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Yes! You can use the Perlego app on both iOS or Android devices to read anytime, anywhere — even offline. Perfect for commutes or when you’re on the go.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Yes, you can access Methods and Applications of Statistics in Clinical Trials, Volume 2 by Narayanaswamy Balakrishnan, N. Balakrishnan in PDF and/or ePUB format, as well as other popular books in Medicine & Biostatistics. We have over one million books available in our catalogue for you to explore.

Information

Publisher
Wiley
Year
2014
Print ISBN
9781118304761
eBook ISBN
9781118595961
Edition
1

Table of contents

  1. Cover
  2. Half Title page
  3. Title page
  4. Copyright page
  5. Contributors
  6. Preface
  7. Chapter 1: Analysis of Over- and Underdispersed Data
  8. Chapter 2: Analysis of Variance (ANOVA)
  9. Chapter 3: Assessment of Health-Related Quality of Life
  10. Chapter 4: Bandit Processes and Response-Adaptive Clinical Trials: The Art of Exploration Versus Exploitation
  11. Chapter 5: Bayesian Dose-Finding Designs in Healthy Volunteers
  12. Chapter 6: Bootstrap
  13. Chapter 7: Conditional Power in Clinical Trial Monitoring
  14. Chapter 8: Cost-Effectiveness Analysis
  15. Chapter 9: Cox-Type Proportional Hazards Models
  16. Chapter 10: Empirical Likelihood Methods in Clinical Experiments
  17. Chapter 11: Frailty Models
  18. Chapter 12: Futility Analysis
  19. Chapter 13: Imaging Science in Medicine I: Overview
  20. Chapter 14: Imaging Science in Medicine, II: Basics of X-Ray Imaging
  21. Chapter 15: Imaging Science in Medicine, III: Digital (21st Century) X-Ray Imaging
  22. Chapter 16: Intention-to-Treat Analysis
  23. Chapter 17: Interim Analyses
  24. Chapter 18: Interrater Reliability
  25. Chapter 19: Intrarater Reliability
  26. Chapter 20: Kaplan—Meier Plot
  27. Chapter 21: Logistic Regression
  28. Chapter 22: Metadata
  29. Chapter 23: Microarray
  30. Chapter 24: Multi-Armed Bandits, Gittins Index, and Its Calculation
  31. Chapter 25: Multiple Comparisons
  32. Chapter 26: Multiple Evaluators
  33. Chapter 27: Noncompartmental Analysis
  34. Chapter 28: Nonparametric ROC Analysis for Diagnostic Trials
  35. Chapter 29: Optimal Biological Dose for Molecularly Targeted Therapies
  36. Chapter 30: Over- and Underdispersion Models
  37. Chapter 31: Permutation Tests in Clinical Trials
  38. Chapter 32: Pharmacoepidemiology, Overview
  39. Chapter 33: Population Pharmacokinetic and Pharmacodynamic Methods
  40. Chapter 34: Proportions: Inferences and Comparisons
  41. Chapter 35: Publication Bias
  42. Chapter 36: Quality of Life
  43. Chapter 37: Relative Risk Modeling
  44. Chapter 38: Sample Size Considerations for Morbidity/Mortality Trials
  45. Chapter 39: Sample Size for Comparing Means
  46. Chapter 40: Sample Size for Comparing Proportions
  47. Chapter 41: Sample Size for Comparing Time-to-Event Data
  48. Chapter 42: Sample Size for Comparing Variabilities
  49. Chapter 43: Screening, Models of
  50. Chapter 44: Screening Trials
  51. Chapter 45: Secondary Efficacy End Points
  52. Chapter 46: Sensitivity, Specificity, and Receiver Operator Characteristic (ROC) Methods
  53. Chapter 47: Software for Genetics/Genomics
  54. Chapter 48: Stability Study Designs
  55. Chapter 49: Subgroup Analysis
  56. Chapter 50: Survival Analysis, Overview
  57. Chapter 51: The FDA and Regulatory Issues
  58. Chapter 52: The Kappa Index
  59. Chapter 53: Treatment Interruption
  60. Chapter 54: Trial Reports: Improving Reporting, Minimizing Bias, and Producing Better Evidence-Based Practice
  61. Chapter 55: U.S. Department of Veterans Affairs Cooperative Studies Program
  62. Chapter 56: Women’s Health Initiative: Statistical Aspects and Selected Early Results
  63. Chapter 57: World Health Organization (WHO): Global Health Situation
  64. Index